ATB.RO · BVB
Antibiotice: financial statements
Financially weak · see the checkFigures in RON, fiscal years
Revenue and net income
Margins
Returns
Income statement
| RON | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | Last year |
|---|---|---|---|---|---|---|---|
| Revenue | 340M RON | 366M RON | 484M RON | 601M RON | 675M RON | 645M RON | -4% |
| Operating income | 33.7M RON | 34.0M RON | 69.9M RON | 96.5M RON | 107M RON | 71.0M RON | -34% |
| EBITDA | 55.5M RON | 58.2M RON | 95.2M RON | 124M RON | 152M RON | 124M RON | -19% |
| Interest expense | 5.4M RON | 3.7M RON | 3.6M RON | 4.1M RON | 4.5M RON | 4.5M RON | -2% |
| Profit before tax | 28.3M RON | 30.3M RON | 65.3M RON | 91.5M RON | 103M RON | 60.1M RON | -42% |
| Income tax | 1.9M RON | 363K RON | 13.8M RON | 10.4M RON | 910K RON | 8.4M RON | +821% |
| Net income | 26.4M RON | 29.9M RON | 51.5M RON | 81.1M RON | 102M RON | 51.8M RON | -49% |
Cash flow
| RON | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | Last year |
|---|---|---|---|---|---|---|---|
| Depreciation & amortization | 21.8M RON | 24.1M RON | 25.3M RON | 27.9M RON | 45.1M RON | 53.0M RON | +18% |
Balance sheet
| RON | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | Last year |
|---|---|---|---|---|---|---|---|
| Cash | 6.3M RON | 2.1M RON | 1.7M RON | 1.8M RON | 2.7M RON | 9.9M RON | +271% |
| Inventory | 109M RON | 106M RON | 143M RON | 160M RON | 170M RON | 182M RON | +7% |
| Current assets | 375M RON | 385M RON | 352M RON | 401M RON | 475M RON | 506M RON | +7% |
| Total assets | 863M RON | 895M RON | 984M RON | 1.1B RON | 1.3B RON | 1.4B RON | +9% |
| Current liabilities | 187M RON | 199M RON | 137M RON | 190M RON | 235M RON | 250M RON | +7% |
| Financial debt | 161M RON | 145M RON | 81.0M RON | 66.3M RON | 141M RON | 233M RON | +66% |
| Total liabilities | 286M RON | 290M RON | 243M RON | 292M RON | 385M RON | 460M RON | +20% |
| Shareholders' equity | 577M RON | 605M RON | 741M RON | 847M RON | 894M RON | 932M RON | +4% |
| Net debt | 155M RON | 143M RON | 79.3M RON | 64.5M RON | 138M RON | 224M RON | +62% |
Ratios
| 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | Last year | |
|---|---|---|---|---|---|---|---|
| Operating margin | 9.9% | 9.3% | 14.5% | 16.1% | 15.9% | 11.0% | |
| Net margin | 7.8% | 8.2% | 10.6% | 13.5% | 15.1% | 8.0% | |
| Return on equity | 4.6% | 4.9% | 6.9% | 9.6% | 11.4% | 5.6% | |
| Return on assets | 3.1% | 3.3% | 5.2% | 7.1% | 8.0% | 3.7% | |
| Return on invested capital | 4.3% | 4.5% | 7.0% | 9.9% | 11.0% | 5.6% | |
| Debt / equity | 0.28 | 0.24 | 0.11 | 0.08 | 0.16 | 0.25 | |
| Net debt / EBITDA | 2.8x | 2.5x | 0.8x | 0.5x | 0.9x | 1.8x | |
| Interest coverage | 6.3x | 9.1x | 19.5x | 23.3x | 23.7x | 15.9x | |
| Current ratio | 2.01 | 1.93 | 2.57 | 2.11 | 2.02 | 2.02 | |
| Quick ratio | 1.43 | 1.40 | 1.53 | 1.27 | 1.30 | 1.29 |
Data source: Bucharest Stock Exchange (ESEF), company annual reports. Lines a company does not report are left empty. Free cash flow is operating cash flow minus capital expenditure. Ratios use the same formulas as the EdgeScore check.
For information and education only. Not investment advice. Data may contain errors.